https://www.selleckchem.com/pr....oducts/orforglipron-
A multiinstitutional study was conducted to analyze prognosticators of completely resected and pathologic T3 N0 M0 (pT3 N0 M stage thymic epithelial tumors. A total of 607 patients with surgically treated thymic epithelial tumors between June 1988 and December 2017 were enrolled. A Cox proportional hazards model and an inverse probability of treatment weighting-adjusted analysis using the propensity score were performed. A total of 394 patients with thymoma and 130 patients with thymic carcinoma underwent complete tumor
Me gusta
Comentario
Compartir
